Molecular docking showed that this compound binds strongly to METTL1. Functional tests demonstrated that it inhibits HGSOC cell proliferation and tumor growth by disrupting METTL1-mediated m7G modification of BRCA1. Overexpression of METTL1 or BRCA1 negated its anti-tumor effects. Here, METTL1 is linked to neoplasm.